RAGE Biotech has been selected as a Featured Company at the American Thoracic Society Respiratory Innovation Summit. The RIS is a unique forum, a concentrated gathering of key influencers in respiratory health innovation, with representatives from major stakeholders: innovators, pharma companies, investors, thought leaders, and most important, patient groups. For more on the ATS-RIS, you can check the news page on our website.
We are particularly honoured and grateful to be selected for the second year in a row and we’re looking forward to sharing our progress on our life-changing RNA therapeutics for chronic lung disease. If you’re at ATS2024 in San Diego, we’ll be at the RIS all day Saturday May 18. See you there!